Govt notifies 2 New SEZs in Puducherry (See 'Corp Brief') Govt of Odisha, Intel and 3DGS ink MoU to bring substrate manufacturing technology to India (See 'Corp Brief') NITI Aayog releases 'Future of India's Semiconductor Industry' Roadmap (See 'Corp Brief') Goyal meets US industry leaders in NY (See 'Corp Brief') Govt hosts Roadshow for Promotion of Lignite Gasification Projects (See 'Corp Brief') Team Agriculture at Kharif Conclave; farming will get a new direction: Chouhan (See 'Corp Brief') A&C - Order of arbitral tribunal accepting objection that it lacks jurisdiction over party sought to be impleaded as non-signatory veritable party is appealable u/s 37(2)(a) of Arbitration Act: HC (See 'Legal Desk') Vaishnaw holds meeting with industry on Revamp of AI Curriculum (See 'Corp Brief') Khadse calls for Mission-Mode People's Movement Against Drug Abuse (See 'Corp Brief') Cooperative Sugar Sector to be strengthened through Circular Economy Model (See 'Corp Brief') IBC - Term loans are repayable through continuing instalment schedules, limitation for Section 7 proceedings is not exhausted merely because some earliest instalments may have become time-barred: NCLT (See 'Legal Desk') First Indigenous Hydrogen Train all set to start (See 'Corp Brief') NI Act - If directors are vicariously liable u/s 141 of NI Act and are themselves undergoing insolvency or bankruptcy, they are not entitled to benefit of moratorium in respect of their personal criminal liability u/s 138 of NI Act: SC (See 'Legal Desk') Ministry of Coal to Organize Roadshow on Surface Coal & Lignite Gasification Projects (See 'Corp Brief') IBC - Appeal without certified copy of impugned order, and without application for exemption from filing certified copy, is wholly incompetent appeal that does not satisfy essential requirements under NCLAT Rules: SC (See 'Legal Desk') DFS organises Credit Outreach Programme at Udaipur, Tripura (See 'Corp Brief') Competition Law - Competition Act did not confer any power on CCI to keep approval u/s 31(1) in respect of Amazon-Future coupon investment, in abeyance or compel fresh Form II filing after approval: SC (See 'Legal Desk') Experts deliberate on Standardised Coding System for Ayurveda under WHO-ICHI Initiative (See 'Corp Brief') IPR - Confusion at initial stage is sufficient to attract infringement: HC (See 'Legal Desk') DFS reviews Performance of North-East RRBs (See 'Corp Brief') IISc-led Semiconductor Training Initiative records Massive Growth in Tribal Youth Participation (See 'Corp Brief') CCI approves JV between Mercuria Energy & Tata International (See 'Corp Brief') CCI approves merger of Indovida India with and into EPL Limited (See 'Corp Brief') Union Minister launches PM-AJAY Portal & AJAY Mobile App to digitize SC welfare schemes (See 'Corp Brief') A&C - SpiceJet is directed to deposit outstanding amount immediately while also applying costs: HC (See 'Legal Desk') Gadkari reviews Monsoon Preparedness for Safer Highways (See 'Corp Brief') Skymap Pharmaceuticals approved as Strategic Buyer for disinvestment of IMPCL (See 'Corp Brief') PM-WANI Ecosystem undergoes Comprehensive Transformation to enable Inclusive Digital Connectivity (See 'Corp Brief') Sales of Khadi and Village Industry Products surpasses Rs 1.87 Lakh Crore-mark (See 'Corp Brief') SARFAESI - Suit's substantive reliefs concern specific performance and enforcement of agreements, plaint cannot be rejected at threshold under Order VII Rule 11 CPC merely because SARFAESI measures are also in background: HC (See 'Legal Desk') Reddy directs Agencies to Fast-Track Pending Mining & Exploration Projects (See 'Corp Brief') Meghalaya Minister discusses STI Hubs for Tribal Communities in Northeast with MoS (See 'Corp Brief') Govt strengthening Preventive Healthcare through Yoga and Naturopathy: Jadhav (See 'Corp Brief') Gadkari reviews NH Projects in Rajasthan and HP (See 'Corp Brief') Secretary reviews Progress of Mineral Block Auctions and Operationalisation (See 'Corp Brief') FERA - Receipt by person in India of Indian currency through cheque drawn on NRE account, even if that account had been funded by foreign currency deposits, does not by itself constitute contravention of Sec 8(1): HC (See 'Legal Desk') Parcel and Logistics Services register 70% growth; Revenue Potential pegged at Rs.10,000 Crore (See 'Corp Brief') Department of Consumer Affairs holds stakeholder meeting on Different Pack Sizes for Edible Oils (See 'Corp Brief') 'Spice and Heal' Initiative can Position India as Global Wellness Leader: Jadhav (See 'Corp Brief') Competition Act - Allegations relating to use of unlicensed/private vehicles & regulatory violations is not competition law issue u/s 3 and 4 of Competition Act: CCI (See 'Legal Desk') Moratorium under the IBC (See CORP EINSICHT) NMDC launches Summer Camp for 1700 Children in Dakshin Bastar (See 'Corp Brief') Benami Act - Confiscation under Benami Act is civil consequence and distinct from prosecution: SC (See 'Legal Desk') 'Janjati Samagam' will, in coming years, gain global recognition as Kumbh of tribal communities (See 'Corp Brief') At Siliguri's 19th employment fair, 82 young people receive appointment letters (See 'Corp Brief') IBC - During subsistence of moratorium u/s 14 IBC, lessor cannot terminate subsisting lease and recover possession of leased property occupied by corporate debtor by invoking contractual breach clauses: HC (See 'Legal Desk')

Print

India Pharma 2026: Spotlight on Policy, Regulation, AI and CRDMO

Published: Apr 14, 2026

By TIOLCorplaws News Service

NEW DELHI, APR 14, 2026: THE first day of the 9th India Pharma 2026 witnessed four high-impact plenary sessions that brought together policymakers, industry leaders, regulators and technology experts to chart the future of India's pharmaceutical and life sciences ecosystem. The discussions reflected a strong consensus on accelerating innovation through policy support, regulatory transformation and adoption of next-generation technologies.

The inaugural plenary session on "Policy Thrust for Catalysing Innovation", highlighted the urgent need to bridge the gap between policy intent and on-ground execution. Manoj Joshi, Secretary, Department of Pharmaceuticals, emphasised industry-led model for Research and Development, importance of strengthening government lab networks and attuning regulatory model to that of European systems. Rajiv Bahl, Secretary Department of Health Research said though research funding has increased manifold over the last few years, the country needs a Bharat model of R & D with confidence of the market in the innovators and increased trust between industry and academica. Industry leaders echoed the need for increased venture capital participation and co-funding mechanisms to nurture research-driven enterprises, stronger industry-academia integration and underscored the importance of integrated ecosystems to translate early-stage discoveries into global solutions. The session concluded with a strong call to "Discover in India" and position the country as a global innovation hub.

The second plenary session on "Enabling Regulatory Ecosystem to Foster Innovation" focused on creating a predictable, efficient and globally aligned regulatory framework. Dr. Rajeev Singh Raghuvanshi, Drug Controller General of India highlighted the importance of stakeholder consultations in shaping responsive regulatory systems. Industry Experts called for expedited approval pathways, single-window clearance mechanisms and greater global harmonisation to reduce duplication and accelerate patient access. Industry leaders further underlined the need for digital enablement and continuous collaboration between regulators and industry. The session underscored that a future-ready regulatory ecosystem will be critical to unlocking next-generation therapies and strengthening India's global competitiveness.

The third plenary session on "Harnessing AI and Next-Gen Technologies for Disruptive Innovation"   explored the transformative potential of artificial intelligence across the pharmaceutical value chain. Pharma leaders emphasised reimagining processes rather than merely digitising existing systems. They highlighted the growing importance of strong data and technology foundations to enable scalable AI adoption and  stressed the immediate benefits of automation in improving clinical efficiency. The session concluded on a forward-looking note, with experts agreeing that AI will play a pivotal role in accelerating drug discovery, enabling precision medicine and shaping a smarter, innovation-led healthcare ecosystem.

The fourth plenary session on "Unleashing India's CRDMO Potential" brought focus to India's growing role in the global Contract Research, Development and Manufacturing Organization (CRDMO) landscape. The panel noted that India's CRDMO industry, currently valued at around $8 billion, has been growing at a robust pace of 10-12 percent, reflecting strong global outsourcing demand. Industry leaders stressed that speed will be a critical differentiator in scaling India's R&D and manufacturing capabilities, and highlighted the transformative role of AI and digital technologies, including digital twins, in reshaping the CRDMO ecosystem. The session concluded by outlining the strategic priorities required for India to lead the next phase of global growth in complex modalities and outsourced pharma services.

Overall, the plenary sessions on Day 1 of India Pharma 2026 reinforced India's readiness to lead the next phase of global pharmaceutical innovation, driven by policy intent, regulatory agility and technological advancement.

 

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.